Modulating the radiation response

Stem Cells

Volumn 14, Issue 1, 1996, Pages 10-15

  Norman Coleman, C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

Radiation biology; Radiation modifiers; Radiation oncology; Radiation sensitizers; Radiation therapy; Sensitizers

Indexed keywords

2 NITROIMIDAZOLE DERIVATIVE; 5 NITROIMIDAZOLE DERIVATIVE; AMIFOSTINE; BUTHIONINE SULFOXIMINE; CISPLATIN; ETANIDAZOLE; GLUTATHIONE; MISONIDAZOLE; MITOMYCIN C DERIVATIVE; NIMORAZOLE; NORMISONIDAZOLE; RADIOPROTECTIVE AGENT; RADIOSENSITIZING AGENT; TIRAPAZAMINE;

CANCER RADIOTHERAPY; CELL SURVIVAL; DNA DAMAGE; DRUG RESISTANCE; HUMAN; HYPERBARIC OXYGEN; HYPOXIC CELL; IONIZING RADIATION; NEUROTOXICITY; RADIATION DOSE FRACTIONATION; RADIATION PROTECTION; RADIOSENSITIZATION; REVIEW; TUMOR GROWTH;

EID: 9044226524     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140010     Document Type: Review

References (35)

1. Coleman CN. Radiation and chemotherapy sensitizer and protectors. In: Chabner BA, Collins JM, eds. Cancer Chemotherapy: Principles & Practice. Philadelphia: J. B. Lippincott, 1995 (in press).
2. Coleman CN, Beard CJ, Hlatky L et al. Biochemical modifiers: hypoxic cell sensitizers. In: Mauch PM, Loeffler JS, eds. Radiation Oncology. Technology and Biology. Philadelphia: W. B. Saunders, 1994:56-89.
3. McGinn CJ, Kinsella TJ. Biochemical modifiers: non-hypoxic cell sensitizers. In: Mauch PM, Loeffler JS, eds. Radiation Oncology: Technology and Biology. Philadelphia: W. B. Saunders. 1994:90-112.
4. Phillips TL. Biochemical modifiers: drug-radiation interactions. In: Mauch PM, Loeffler JS, eds. Radiation Oncology: Technology and Biology. Philadelphia: W. B. Saunders, 1994:113-151.
5. Hall EJ. Radiobiology for the Radiologist. Philadelphia: J B. Lippincott, 1994;1-14:113-190.
6. Henk JM. Does hyperbaric oxygen have a future in radiation therapy? Int J Radiat Oncol Biol Phys 1981;7:1125-1128.
7. Teicher BA, Herman TS, Hopkins RE at al. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation. Int J Radiat Oncol Biol Phys 1991;21:969-974.
8. Horsman MR, Kristjansen PEG, Mizuno M et al Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDFI mice. Int J Radiat Oncol Biol Phys 1992;22:451-454.
9. Urtasun R, Band P, Chapman DJ et al. Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med 1976;294:1364-1367.
10. Brown JM. Hypoxic cell radiosensitizers: the end of an era? Int J Radiat Oncol Biol Phys (Editorial). 1995;32:883-885.
11. Stone HB, Brown JM, Phillips TL et al. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiat Res (Letter). 1995:1264-1265.
12. Coleman CN. Reports of my death [may be] greatly exaggerated. Int J Radiat Oncol Biol Phys 1995 (in press).
13. Brown JM. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumors. Br J Cancer 1993;67:1163-1170.
14. Workman P. Keynote address: bioreductive mechanisms. Int J Radiat Oncol Biol Phys 1992;22:631-637.
15. Palayoor ST, Bump EA, Malaker K et al. Modification of the aerobic cytotoxicity of etanidazole. Int J Radiat Oncol Biol Phys 1994;29:289-293.
16. Hercsher LL, Krishna MC, Cook JA et al. Protection against SR 4233 (tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tiron. Int J Radiat Oncol Biol Phys 1994;30:879-885.
17. Hlatky L, Tsionou C, Hahnfeldt P et al. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 1994;54:6083-6086.
18. Teicher BA, Herman TS. Holden SA et al. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 1990;247:1457-1461.
19. Kirchgessner CU, Patil CK, Evans JW et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID mutation. Science 1995;267:1178-1183.
20. Muschel RJ, Zhang HB, McKenna WG. Differential effect of ionizing radiation on the expression of cylin A and cyclin B in Hela cells. Cancer Res 1993;53:1128-1135.
21. Langley RE, Palayoor ST, Coleman CN et al. Modifiers of radiation-induced apoptosis. Radiat Res 1993;136:320-326.
22. Stevenson MA, Pollock SS, Coleman CN et al. X-irradiation, phorbol esters, and H202 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 1994;54:1512-1519.
23. Uckun FM, Tuel-Ahlgren L, Song CW et al. Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. Proc Natl Acad Sci USA 1992;89:9005-9009.
24. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995;267:1782-1788.
25. Boothman DA, Bouvard I, Hughes EN. Identification and characterization of x-ray-induced proteins in human cells. Cancer Res 1989:2871-2878.
26. Forance AJ, Nebert DW, Hollander MC et al. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 1989;9:4196-4203.
27. Price BD, Calderwood SK. Gadd45 and gadd 153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of glucoseregulated proteins. Cancer Res 1992;52:3814-3817.
28. 1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res 1994;54:5054-5058.
29. Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A et al. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 1991;51:2552-2558.
30. Rubin P. Finkelstein J, Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys 1992,24:93-101.
31. Anscher MS, Murase T, Prescott D et al. Changes in plasma TGFβ3 levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 1994;30:671-676.
32. Weichselbaum RR, Hallahan DE, Beckett MA et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994;54:4266-4269.
33. Kim JH, Kim SH, Brown SL et al. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced by HSV-tk gene. Cancer Res 1994;54:6053-6056.
34. Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 1992;89:33-37.
35. McBride WH, Thacker JD, Comora S et al. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res 1992;52:3931-3937.